Effects of Acetazolamide, Paracetamol, and Placebo on Postoperative Pain in Laparoscopic Cholecystectomy: A Randomized, Double-blind, Parallel-controlled Clinical Trial

Details
Parent Category: Year 2021, Volume 13
Category: Volume 13, Issue 1, January-March 2021
Abstract
Introduction: In laparoscopic surgery, insufflation of CO2 gas into the peritoneal cavity creates referred postoperative pain and diffuse abdominal pain. Referred pain is sometimes more intensive than incisional and abdominal pain. 
Objective: To determine the efficacy of acetazolamide by increasing pH and reducing acidity in the abdomen and to compare the analgesic effects of paracetamol and acetazolamide with a control group in laparoscopic surgery.
Methods: This randomized, double-blind, parallel-controlled clinical trial was conducted on ASA1 (American Society of Anesthesiologists Class 1) patients, who were candidates for laparoscopic cholecystectomy in teaching hospitals affiliated with Mashhad University of Medical Sciences during 2016-2017. One hundred fourteen patients were allocated equally into two study groups and one control group (receiving acetazolamide, paracetamol, or placebo). In the acetazolamide group, 250 mg acetazolamide was administered one hour before anesthesia. In the paracetamol group, 1 g paracetamol was infused over a 15-min postanesthesia induction. Incision site, diffuse abdominal, and shoulder pains were evaluated at the recovery room the day after surgery and upon hospital discharge using a numeric rating scale (NRS). Data were analyzed by SPSS 16.0, using Chi-square for trend test, Fisher's exact test, paired-samples t-test, Wilcoxon signed-rank test, two-way repeated measure analysis of variance (ANOVA), and Mann-Whitney U test. 
Results: There were no significant differences between groups regarding their demographic characteristics. The acetazolamide group exhibited a lower frequency of shoulder pain than the paracetamol and control groups at recovery (p=0.03), 24 hours later (p=0.001), and before discharge (p=0.014). Incisional and diffuse abdominal pains were lower in the paracetamol group (p=0.012). 
Conclusion: In the patients undergoing laparoscopic cholecystectomy, acetazolamide was effective in the reduction of shoulder pain and paracetamol was effective in postoperative incisional and abdominal pain control.
Registration: This study was registered In the Iranian Registry of Clinical Trials under registration number IRCT201206108384N2.
Funding:  Research Vice-chancellor, Mashhad University of Medical Sciences (Ref: 900337).
 
Keywords: Acetazolamide, Paracetamol, Laparoscopic surgery, Referred pain

 

» HTML Fulltext    » PDF Fulltext    » doi: 10.19082/7795

The  most recent editorial (June 2021)

Ethics of Publishing Case Reports: Do We Need Ethics Approval and Patient Consent?

An editorial by Dr. Mehrdad Jalalian

Read more.

The worldwide spread of COVID-19 as an emerging, rapidly evolving situation, and the dramatic need of urgent medicine or vaccine, has rapidly brought new hypotheses for pathophysiology and potential medicinal agents to the fore. It is crucial that the research community provide a way to publish this research in a timely manner.

 

To contribute to this important public health discussion, the Electronic Physician Journal is excited to announce a fast-track procedure to help researchers publish their articles on COVID-19 related subjects that fall under the broad definition of public health, internal medicine, and pharmacology. We are especially welcome to all hypotheses about the pathological basis of the COVID-19 infection and the possible characteristics of potential medicine and vaccine. Submit your manuscript here

 

Our previous editorial (June 2020)

Lessons from COVID-19 pandemic and the Morocco’s success story.

An editorial by Dr. Benksim Abdelhafid (Morocco)

Read more.

 

The 6th World Conference on Research Integrity (WCRI) is to be held on June 2-5, 2019 in Hong Kong.

The WCRI is the largest and most significant international conference on research integrity. Since the first conference in Lisbon in 2007, it has given researchers, teachers, funding agencies, government officials, journal editors, senior administrators, and research students opportunities to share experiences and to discuss and promote integrity in research. Read more:

 

TDR Clinical Research and Development Fellowships

Call for applications

Deadline for submission: 7 March 2019, 16:00 (GMT)

TDR provides fellowships for early- to mid-career researchers and clinical trial staff (e.g. clinicians, pharmacists, medical statisticians, data managers, other health researchers) in low- and middle-income countries (LMICs) to learn how to conduct clinical trials. Read more:

Meta-Analysis Workshops in New York, USA, and London, UK, in April and May 2019

Don't miss this exceptional opportunity to learn how to perform and report a Meta-analysis correctly. Two Meta-analysis workshops are organized in April and May 2019 by Dr. Michael Borenstein in New York, USA (April 08-10, 2019) and London, UK (May 27-29).

About the Instructor

Dr. Michael Borenstein, one of the authors of Introduction to Meta-Analysis, is widely recognized for his ability to make statistical concepts accessible to researchers as well as to statisticians. He has lectured widely on meta-analysis, including at the NIH, CDC, and FDA. Read more: